[Retracted] Antiviral Therapy with Entecavir following Antituberculosis Therapy Alleviates Liver Injury and Restores Innate Immunity in Tuberculosis Patients Coinfected with Hepatitis B Virus

Table 1

Changes of liver function between the two groups before treatment and 6 months after treatment.

Group	Time	ALT (U/L)	AST (U/L)	TBIL (μmol/L)
Anti-TB group (n = 50)	Before treatment	71.87 ± 9.73	76.99 ± 6.32	15.21 ± 2.96
	6 months after treatment	115.77 ± 12.45	107.03 ± 11.85	24.02 ± 4.88
Antiviral group (n = 50)	Before treatment	71.86 ± 9.82	76.00 ± 6.34	15.20 ± 2.87
	6 months after treatment	95.36 ± 8.11	85.68 ± 9.93	19.89 ± 3.75
t/P (within the anti-TB group)		24.183/0.001	34.251/0.001	15.185/0.001
t/P (within the antiviral group)		35.196/0.001	46.842/0.001	21.021/0.001
t/P (between groups)		12.791/0.001	15.564/0.001	7.142/0.001

ALT, alanine aminotransferase; AST, aspartate aminotransferase; TBIL, total bilirubin.